Scientists discover a protein that silences the biological clock
6/03/2015

A protein associated with many kinds of cancer cells was found to suppress the circadian clock, with implications for cancer biology and the workings of the clock itselfA new study led by UC...

Study finds misperceptions about impact of double mastectomy
6/03/2015

Majority of breast cancer patients did not know the aggressive procedure does not improve survivalA survey of women with breast cancer found that nearly half considered having a double mastectomy.

Pediatric sepsis diagnosed in three to five hours versus two to six days data at ASM
6/03/2015

T2 Biosystems, Inc. a company developing innovative diagnostic products to improve patient health, has announced the presentation of results from an investigational study evaluating the...

'Master controller' behind DNA structure reorganization during senescence identified
6/03/2015

Senescence, a phenomenon in which cells cease to divide and grow, can be caused by everything from natural DNA damage to treatment with chemotherapy.

For a good gut feeling
6/03/2015

Trillions of microorganisms colonize our gut and together form the intestinal flora that coats the inside of the intestine.

New research suggests that pre-existing inflammation may promote the spread of cancer
6/03/2015

Although normal inflammation plays an important role in helping to fight off infections, there is mounting evidence that chronic inflammation is linked to increased risk of tumor development.

The European Commission approves Akynzeo for the prevention of chemotherapy induced nausea and vomiting (CINV)
6/03/2015

Helsinn, the Swiss Group focused on building quality cancer care, has announced that on 27th May 2015, the European Commission (EC) approved Akynzeo® (netupitant-palonosetron) for the...

Improving the delivery of chemotherapy with graphene
6/02/2015

A new study published in IOP Publishing's journal 2D Materials has proposed using graphene as an alternative coating for catheters to improve the delivery of chemotherapy drugs.

New data demonstrate improved patient outcomes with matched cancer therapy informed by comprehensive genomic profiling with FoundationOne
6/02/2015

Foundation Medicine, Inc. and collaborators from the University of Texas MD Anderson Cancer Center and Sarah Cannon Research Institute at HealthOne have announced compelling new data demonstrating...

A new perspective on Phantom Eye Syndrome
6/02/2015

Researchers from the University of Liverpool have found that approximately half of patients who have an eye removed because of a form of eye cancer experience 'phantom eye syndrome.